VACCIN H5N1 par Glaxo ? source Reuter

[------phenix----- 0]

GENEVA, June 22 (Reuters) - GlaxoSmithKline Plc plans to seek European approval in October for a new vaccine to prevent bird flu in humans, the head of its vaccines business said on Thursday.

Europe's biggest drugmaker, which started clinical trials of two experimental vaccines in March, has previously said it expected a protective shot would be ready for manufacture by the end of the year.

"We will apply for regulatory approval of a vaccine in October 2006," Jean Stephenne told reporters at a briefing.

Glaxo hopes to have the clinical data necessary to assess the effectiveness of its vaccines by August and September, he added. It also intends to present the results of its clinical studies to a scientific conference in October.



Several drugmakers are working to develop vaccines against the H5N1 strain of bird flu, but Glaxo believes it may have an advantage because it is using special adjuvants -- additives put into vaccines that boost the immune system.

Scientists believe vaccines from Glaxo and rivals such as Sanofi-Aventis (SASY.PA) might protect people from "drifted" strains of H5N1 -- those that have evolved slightly and do not precisely match the strain of virus used in the vaccine.

That could make them a good option for governments building up stockpiles.

The H5N1 strain of avian influenza has spread rapidly out of eastern Asia in recent months. It almost exclusively infects birds but has killed 130 people since 2003, mostly in Asia.

Experts believe it poses the greatest threat yet of a pandemic, a global epidemic of flu that could kill millions, if it acquires the ability to pass easily from human to human.

No one knows how well human H5N1 vaccines will match a future pandemic strain, but they might prime a person's immune system, reducing sickness and death.

The normal seasonal flu vaccine provides no protection against H5N1.

.

[sokol 0]

Cocoricco!

Encore un pas de géant pour l'industrie pharmaceutique du Brabant Wallon!

Le plan Marshall tourne à fond les pistons!

[sokol 0]

and God bless la Wallifornie!

[Hera11 0]

En effet, je travail chez Glaxo et je vous confirme que la fabrication du vaccin est en train de se mettre en place.
Il sera fabriquer en France dans l'usine d'Evreux (Eure).

[------phenix----- 0]

Oui mais ce sera (si mes infos sont correctes) uniquement un vaccin pour les humains, et les autorités consitueraient des stocks "stratégiques".

Pas de nouvelles d'autorisation à ma connaissance pour le bon petit peuple des "ornithophiles"

[Hera11 0]

C'est bien un vaccin humain qui sera fabriqué mais la production n'a pas encore commencé. Ils sont encore en phase de tests si je ne me trompe pas.

Pour les stocks je ne suis pas vraiment au courant mais c'est vrai qu'en général les premières productions sont réservées. Si il n'y a pas de grosse épidémie rapidemment il y aura de quoi faire des stocks pour tout le monde par la suite. (certaines lignes produisent jusqu'à 48 000 seringues par heure!)